"Designing Growth Strategies is in our DNA"

Pen Needles Market Size, Share & Industry Analysis, By Product Type (Standard Pen Needles, and Safety Pen Needles), By Drug Type (Insulin, GLP-1, Growth Hormone, and Others), By Disease Indication (Diabetes, Obesity, Hormone Deficiency, and Others), By Needle Size (4 mm, 5 mm, 6 mm, 8 mm, and 12 mm), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy), and Regional Forecast, 2025-2032

Last Updated: November 17, 2025 | Format: PDF | Report ID: FBI110437

 


To get information on various segments, share your queries with us

ATTRIBUTE

DETAILS

Study Period

2019-2032

Base Year

2024

Estimated Year

2025

Forecast Period

2024-2032

Historical Period

2019-2023

Growth Rate

CAGR of 6.9% from 2024-2032

Unit

Value (USD billion)

 

 

 

 

 

 

 

 

 

 

Segmentation

By Product Type

  • Standard Pen Needles
  • Safety Pen Needles

By Drug Type

  • Insulin
  • GLP-1
  • Growth Hormone
  • Others

By Disease Indication

  • Diabetes
  • Obesity
  • Hormone Deficiency
  • Others

By Needle Size

  • 4 mm
  • 5 mm
  • 6 mm
  • 8 mm
  • 12 mm

By Distribution Channel

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy

By Region

  • North America (By Product Type, By Drug Type, By Disease Indication, By Needle Size, By Distribution Channel, and By Country)
    • U.S.
    • Canada
  • Europe (By Product Type, By Drug Type, By Disease Indication, By Needle Size, By Distribution Channel, and by Country/Sub-region)
    • U.K.
    • Germany
    • France
    • Spain
    • Italy
    • Scandinavia
    • Rest of Europe
  • Asia Pacific (By Product Type, By Drug Type, By Disease Indication, By Needle Size, By Distribution Channel, and by Country/Sub-region)
    • Japan
    • China
    • Australia
    • India
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America (By Product Type, By Drug Type, By Disease Indication, By Needle Size, By Distribution Channel, and by Country/Sub-region)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa (By Product Type, By Drug Type, By Disease Indication, By Needle Size, By Distribution Channel, and by Country/Sub-region)
    • South Africa
    • GCC
  • Rest of Middle East & Africa

 

  • 2019-2032
  • 2024
  • 2019-2023
  • 130
  • Buy Now

    (Offer valid till 15th Dec 2025)

Download Free Sample

    man icon
    Mail icon
Growth Advisory Services
    How can we help you uncover new opportunities and scale faster?
Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann